A U.S. federal judge in Texas denied attempts by the U.S. Food and Drug Administration to conceal data on Pfizer’s COVID-19 vaccine.

Two doses of the Pfizer Inc. and BioNTech SE COVID-19 vaccine are highly protective against a rare but often serious condition in children that causes organ inflammation weeks after COVID-19 infections, a U.S. Centers for Disease Control and Prevention report said on January 7.

The U.S. Department of Health and Human Services (HHS) appears unprepared to assume full responsibility for the nation’s Covid-19 vaccine program, including activities currently managed by the Pentagon, according to a draft government watchdog report reviewed by Reuters.

The U.S. Centers for Disease Control and Prevention (CDC) said on January 5 the agency expanded the eligibility of Pfizer Inc. and BioNTech SE’s booster doses to those 12 to 15 years old.

Pfizer Inc. and Germany’s BioNTech SE will develop an mRNA-based vaccine for viral infection shingles, collaborating for the third time after the success of their COVID-19 vaccine based on the same technology.

The U.S. Centers for Disease Control and Prevention (CDC) on January 4 recommended shortening the interval between Pfizer-BioNTech’s second COVID-19 vaccine dose and the booster shot to five months from six.

Because the Omicron variant of COVID-19 is so infectious, it is surging around the United States. Vaccination is still the best way to prevent severe disease and death, but there is increasing debate on the benefit of yet another booster shot and how long people who show symptoms should quarantine.

BioSpace looks at the 10 biggest drug approvals of 2021, headlined by Biogen’s Aduhelm (aducanumab) for Alzheimer’s disease and Pfizer and BioNTech’s COVID-19 vaccine Comirnaty.

The U.S. Food and Drug Administration on January 3 authorized the use of a third dose of the Pfizer and BioNTech COVID-19 vaccine for children ages 12 to 15, and narrowed the interval for booster shot eligibility to five months from six.

The FDA granted Emergency Use Authorization (EUA) to Pfizer and BioNTech for their COVID-19 vaccine booster shots in kids ages 12 and up.